Rotavirus disease and vaccination

Impact on genotype diversity

Jelle Matthijnssens, Joke Bilcke, Max Ciarlet, Vito Martella, K. Bányai, Mustafizur Rahman, Mark Zeller, Philippe Beutels, Pierre Van Damme, Marc Van Ranst

Research output: Contribution to journalArticle

205 Citations (Scopus)

Abstract

Temporal and spatial fluctuations in the genotype distribution of human rotaviruses are continuously observed in surveillance studies. New genotypes, such as G9 and G12, have emerged and spread worldwide in a very short time span. In addition, reassortment events have the potential to contribute substantially to genetic diversity among human and animal rotaviruses. With the recent introduction of the two rotavirus vaccines, RotaTeq™ and Rotarix™, in many countries, it appears that the total number of hospitalizations due to rotavirus infections is being reduced, at least in developed countries that implemented a universal immunization program. However, continued surveillance is warranted, especially regarding the long-term effects of the vaccines. No data analyses are available to clarify whether rotavirus vaccine introduction would allow other rotavirus P and G genotypes, which are not covered by the current vaccines, to emerge into the human population and fill the apparent gap. This kind of data ana lysis is essential, but its interpretation is hampered by natural and cyclical genotype fluctuations.

Original languageEnglish
Pages (from-to)1303-1316
Number of pages14
JournalFuture Microbiology
Volume4
Issue number10
DOIs
Publication statusPublished - Dec 2009

Fingerprint

Rotavirus
Vaccination
Genotype
Rotavirus Vaccines
Vaccines
Rotavirus Infections
Immunization Programs
Developing Countries
Hospitalization
Population

Keywords

  • Burden of disease
  • Epidemiology
  • Genetic diversity
  • Rotavirus
  • Vaccines

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)

Cite this

Matthijnssens, J., Bilcke, J., Ciarlet, M., Martella, V., Bányai, K., Rahman, M., ... Van Ranst, M. (2009). Rotavirus disease and vaccination: Impact on genotype diversity. Future Microbiology, 4(10), 1303-1316. https://doi.org/10.2217/fmb.09.96

Rotavirus disease and vaccination : Impact on genotype diversity. / Matthijnssens, Jelle; Bilcke, Joke; Ciarlet, Max; Martella, Vito; Bányai, K.; Rahman, Mustafizur; Zeller, Mark; Beutels, Philippe; Van Damme, Pierre; Van Ranst, Marc.

In: Future Microbiology, Vol. 4, No. 10, 12.2009, p. 1303-1316.

Research output: Contribution to journalArticle

Matthijnssens, J, Bilcke, J, Ciarlet, M, Martella, V, Bányai, K, Rahman, M, Zeller, M, Beutels, P, Van Damme, P & Van Ranst, M 2009, 'Rotavirus disease and vaccination: Impact on genotype diversity', Future Microbiology, vol. 4, no. 10, pp. 1303-1316. https://doi.org/10.2217/fmb.09.96
Matthijnssens J, Bilcke J, Ciarlet M, Martella V, Bányai K, Rahman M et al. Rotavirus disease and vaccination: Impact on genotype diversity. Future Microbiology. 2009 Dec;4(10):1303-1316. https://doi.org/10.2217/fmb.09.96
Matthijnssens, Jelle ; Bilcke, Joke ; Ciarlet, Max ; Martella, Vito ; Bányai, K. ; Rahman, Mustafizur ; Zeller, Mark ; Beutels, Philippe ; Van Damme, Pierre ; Van Ranst, Marc. / Rotavirus disease and vaccination : Impact on genotype diversity. In: Future Microbiology. 2009 ; Vol. 4, No. 10. pp. 1303-1316.
@article{8d319c0236e643e5898d2f79e0ac138f,
title = "Rotavirus disease and vaccination: Impact on genotype diversity",
abstract = "Temporal and spatial fluctuations in the genotype distribution of human rotaviruses are continuously observed in surveillance studies. New genotypes, such as G9 and G12, have emerged and spread worldwide in a very short time span. In addition, reassortment events have the potential to contribute substantially to genetic diversity among human and animal rotaviruses. With the recent introduction of the two rotavirus vaccines, RotaTeq™ and Rotarix™, in many countries, it appears that the total number of hospitalizations due to rotavirus infections is being reduced, at least in developed countries that implemented a universal immunization program. However, continued surveillance is warranted, especially regarding the long-term effects of the vaccines. No data analyses are available to clarify whether rotavirus vaccine introduction would allow other rotavirus P and G genotypes, which are not covered by the current vaccines, to emerge into the human population and fill the apparent gap. This kind of data ana lysis is essential, but its interpretation is hampered by natural and cyclical genotype fluctuations.",
keywords = "Burden of disease, Epidemiology, Genetic diversity, Rotavirus, Vaccines",
author = "Jelle Matthijnssens and Joke Bilcke and Max Ciarlet and Vito Martella and K. B{\'a}nyai and Mustafizur Rahman and Mark Zeller and Philippe Beutels and {Van Damme}, Pierre and {Van Ranst}, Marc",
year = "2009",
month = "12",
doi = "10.2217/fmb.09.96",
language = "English",
volume = "4",
pages = "1303--1316",
journal = "Future Microbiology",
issn = "1746-0913",
publisher = "Future Medicine Ltd.",
number = "10",

}

TY - JOUR

T1 - Rotavirus disease and vaccination

T2 - Impact on genotype diversity

AU - Matthijnssens, Jelle

AU - Bilcke, Joke

AU - Ciarlet, Max

AU - Martella, Vito

AU - Bányai, K.

AU - Rahman, Mustafizur

AU - Zeller, Mark

AU - Beutels, Philippe

AU - Van Damme, Pierre

AU - Van Ranst, Marc

PY - 2009/12

Y1 - 2009/12

N2 - Temporal and spatial fluctuations in the genotype distribution of human rotaviruses are continuously observed in surveillance studies. New genotypes, such as G9 and G12, have emerged and spread worldwide in a very short time span. In addition, reassortment events have the potential to contribute substantially to genetic diversity among human and animal rotaviruses. With the recent introduction of the two rotavirus vaccines, RotaTeq™ and Rotarix™, in many countries, it appears that the total number of hospitalizations due to rotavirus infections is being reduced, at least in developed countries that implemented a universal immunization program. However, continued surveillance is warranted, especially regarding the long-term effects of the vaccines. No data analyses are available to clarify whether rotavirus vaccine introduction would allow other rotavirus P and G genotypes, which are not covered by the current vaccines, to emerge into the human population and fill the apparent gap. This kind of data ana lysis is essential, but its interpretation is hampered by natural and cyclical genotype fluctuations.

AB - Temporal and spatial fluctuations in the genotype distribution of human rotaviruses are continuously observed in surveillance studies. New genotypes, such as G9 and G12, have emerged and spread worldwide in a very short time span. In addition, reassortment events have the potential to contribute substantially to genetic diversity among human and animal rotaviruses. With the recent introduction of the two rotavirus vaccines, RotaTeq™ and Rotarix™, in many countries, it appears that the total number of hospitalizations due to rotavirus infections is being reduced, at least in developed countries that implemented a universal immunization program. However, continued surveillance is warranted, especially regarding the long-term effects of the vaccines. No data analyses are available to clarify whether rotavirus vaccine introduction would allow other rotavirus P and G genotypes, which are not covered by the current vaccines, to emerge into the human population and fill the apparent gap. This kind of data ana lysis is essential, but its interpretation is hampered by natural and cyclical genotype fluctuations.

KW - Burden of disease

KW - Epidemiology

KW - Genetic diversity

KW - Rotavirus

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=74749096213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74749096213&partnerID=8YFLogxK

U2 - 10.2217/fmb.09.96

DO - 10.2217/fmb.09.96

M3 - Article

VL - 4

SP - 1303

EP - 1316

JO - Future Microbiology

JF - Future Microbiology

SN - 1746-0913

IS - 10

ER -